FdaApplication
NDA 210583
Identifiers
- fda_app_no: NDA210583
Properties
| Property | Value |
|---|---|
| applicant_name | BAUDAX BIO INC |
| application_type | NDA |
| approval_date | 2020-02-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ANJESO | MELOXICAM | 30MG/ML (30MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;INTRAVENOUS |
1 product